Search for: "Lee v. Small Claims Court" Results 281 - 300 of 374
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Feb 2021, 10:56 am by Jacob Schulz
Before the Hutaree case, the Justice Department had brought seditious conspiracy charges only three times in the previous 20 years: twice for small U.S. al-Qaeda cells and once for the Blind Sheikh and other al-Qaeda operatives responsible for the 1993 World Trade Center bombing and a planned spree of terror attacks around the New York area. [read post]
2 Mar 2020, 10:14 am by Rebecca Tushnet
  We all cite the Lee et al study on identifying terms as trademarks by their placement on the package, but what about replicability? [read post]
30 May 2008, 9:09 am
– Brdo: (IPR-Helpdesk), 5-6 June: USFDA public meeting on evaluation of product trade names: (FDA Law Blog), 5-7 June: European research and innovation exhibition – Paris: (IPR-Helpdesk), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with… [read post]
6 Jun 2008, 6:49 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: YouTube – Prince demands removal of song from YouTube, Radiohead demand it is put back online: (Techdirt), (Electronic Frontier Foundation), (The Trademark Blog), Japan planning fair use provision: (Michael Geist), (Techdirt), (IP Justice), (Patry Copyright Blog), Judge rejects Yoko Ono’s request for preliminary injunction… [read post]
12 Jun 2018, 12:23 pm by Sandy Levinson
Taney didn't do it, but, if one can accept Story's similarly-motivated opinion in Prigg v. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
7 Sep 2011, 4:11 pm by Lawrence Higgins
The program will cover: recent developments in claims construction and claims drafting, cost savings in litigation, inequitable conduct after Therasense, and many other topics. [read post]
21 Aug 2013, 3:23 am by Thornhill Law Firm, A PLC
Insurance in Sanibel Island’s Lee County is concerned spiraling rates will both dampen real estate sales and hurt small business. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
14 Apr 2016, 2:02 pm by Jared Beck
Circuit, Garland joined that court’s opinion in SpeechNow.org v. [read post]
30 Jul 2018, 10:44 am by Lisa Ouellette
West-Ward, holding that step requiring action based on diagnostic result rendered a claim patent eligible, is good news.Amy Motomura – Allowing a patentee's own past patent applications to serve as prior art discourages valuable disclosure. [read post]
11 Apr 2017, 3:01 pm
It is at this point that corporate social responsibility becomes interesting to the law--the lawyer, to the legislator, to the administrator and the courts. [read post]
4 Jan 2021, 1:26 pm by Kevin LaCroix
(Please note that these filing figures represent federal court filings only; the figures do not include separate state court class action lawsuit filings.) [read post]
11 Aug 2016, 3:41 pm by Rebecca Tushnet
David Hyman & David Franklyn A couple of small empirical studies and armchair empiricism; lots of regulatory interest. [read post]